Clinica pediatrica, IRCCS G.Gaslini, Genova, Italy.
UOC Pediatria e Neonatologia, Ospedale S.Paolo, Savona, Italy.
J Diabetes Sci Technol. 2021 Sep;15(5):1098-1103. doi: 10.1177/1932296820934803. Epub 2020 Jun 19.
The aim of the study was to determine the effect of an educational intervention on the use of trend arrows of a real-time continuous glucose monitoring (rt-CGM) to manage daily therapy decisions in a group of adolescents with type 1 diabetes attending a camp. The secondary aim was to evaluate the variations in total daily dose (TDD) of insulin requirement.
Twenty patients (15-17 years) on multiple insulin injections ( = 8) or continuous subcutaneous insulin infusion ( = 12) attended a training session at the beginning of the camp to learn our algorithm for the management of therapy depending on trend arrows. TDD, time in range (TIR), time above range (TAR), and time below range (TBR) (in the 24 hours and in the three hours after breakfast) before the training session (run-in) and at the end of the camp (T1) were analyzed.
Data showed a reduction of TAR (run-in 42.6%, T1 32.05%, = .036) and an increase in TIR (run-in 52.9%, T1 62.4%, = .013). Reduction of TBR (run-in 42.5%, T1 37.5%, = .05) and improvement in TIR (run-in 49.0%, T1 57.0%, = .02) were also observed in the post-breakfast period. Data showed a significant reduction in the TDD (run-in 52.02 ± 17.44 U/die, T1 46.49 ± 12.39 U/die, = .024).
Statistically significant improvement of glycemic control and reduction of TTD were observed in all patients regardless of therapy type. The improvement between run-in and T1 demonstrates the importance of patients' education on the correct use of rt-CGM with simple algorithms for the management of therapy.
本研究旨在确定在参加夏令营的一群 1 型糖尿病青少年中,教育干预对实时连续血糖监测(rt-CGM)趋势箭头使用以管理日常治疗决策的影响。次要目的是评估胰岛素需求的总日剂量(TDD)的变化。
20 名(15-17 岁)接受多次胰岛素注射(=8)或持续皮下胰岛素输注(=12)的患者在夏令营开始时参加了一次培训课程,学习我们根据趋势箭头管理治疗的算法。分析了培训课程前(运行期)和夏令营结束时(T1)的 TDD、血糖控制在目标范围内时间(TIR)、血糖高于目标范围时间(TAR)、血糖低于目标范围时间(TBR)(24 小时内和早餐后 3 小时内)。
数据显示 TAR 降低(运行期 42.6%,T1 32.05%,=0.036)和 TIR 升高(运行期 52.9%,T1 62.4%,=0.013)。早餐后 TBR 降低(运行期 42.5%,T1 37.5%,=0.05)和 TIR 改善(运行期 49.0%,T1 57.0%,=0.02)也观察到。TDD 显著降低(运行期 52.02±17.44U/die,T1 46.49±12.39U/die,=0.024)。
无论治疗类型如何,所有患者的血糖控制均显著改善,TDD 降低。运行期和 T1 之间的改善表明,对患者进行正确使用 rt-CGM 以及使用简单算法管理治疗的教育非常重要。